Literature DB >> 30825757

Clinical Outcomes and Costs Following Unplanned Excisions of Soft Tissue Sarcomas in the Elderly.

Sarah B Bateni1, Alicia A Gingrich1, Sun Y Jeon2, Jeffrey S Hoch2, Steven W Thorpe3, Amanda R Kirane1, Richard J Bold1, Robert J Canter4.   

Abstract

BACKGROUND: Surgical guidelines for soft tissue sarcoma (STS) emphasize pretreatment evaluation and reports of the perils of unplanned excision exist. Given the paucity of population-based data on this topic, our objective was to analyze clinical outcomes and costs of planned versus unplanned STS excisions in the Medicare population.
METHODS: We analyzed 3913 surgical patients with STS ≥66 y old from 1992 to 2011 using the Surveillance, Epidemiology, and End Results-Medicare datafiles. Planned excisions were classified based on preoperative MRI and/or biopsy, whereas unplanned excisions were classified by excision as the first procedure. Inverse probability of treatment weighting with propensity scores was used to adjust for clinicopathologic differences. Re-excisions, complications, and Medicare payments were compared with multivariate models. Overall survival and disease-specific survival were analyzed using Cox proportional hazards and competing risk models.
RESULTS: Before the first excision, 24.3% had an MRI and biopsy, 27.3% had an MRI, 11.4% had a biopsy, and 36.9% were unplanned. Re-excision rates were highest for unplanned excisions: 46.3% compared to 18.1%, 36.4%, and 29.7% for other groups (P < 0.0001). There was no difference in disease-specific survival or overall survival between groups (P > 0.05). Planned excisions were associated with increased Medicare costs (P < 0.05), with the first resection contributing to the majority of costs. Subgroup analyses by histologic grade and tumor size revealed similar results.
CONCLUSIONS: Survival was comparable with greater health care costs in elderly patients undergoing planned STS excision. Although unplanned excisions remain a quality of care issue with high re-excision rates, these data have important implications for the surgical management of STS in the elderly.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biopsy; Cost; MRI; Sarcoma; Survival

Mesh:

Year:  2019        PMID: 30825757      PMCID: PMC6488355          DOI: 10.1016/j.jss.2019.01.055

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  37 in total

1.  Adverse effect of older age on the recurrence of soft tissue sarcoma of the extremities and trunk.

Authors:  David J Biau; Peter C Ferguson; Robert E Turcotte; Peter Chung; Marc H Isler; Soha Riad; Anthony M Griffin; Charles N Catton; Brian O'Sullivan; Jay S Wunder
Journal:  J Clin Oncol       Date:  2011-09-19       Impact factor: 44.544

2.  Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Authors:  Joan L Warren; Carrie N Klabunde; Deborah Schrag; Peter B Bach; Gerald F Riley
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

3.  Complications, failure to rescue, and mortality with major inpatient surgery in medicare patients.

Authors:  Amir A Ghaferi; John D Birkmeyer; Justin B Dimick
Journal:  Ann Surg       Date:  2009-12       Impact factor: 12.969

4.  Hospital quality and the cost of inpatient surgery in the United States.

Authors:  John D Birkmeyer; Cathryn Gust; Justin B Dimick; Nancy J O Birkmeyer; Jonathan S Skinner
Journal:  Ann Surg       Date:  2012-01       Impact factor: 12.969

5.  A population-based study of the quality of care in the diagnosis of large (≥5 cm) soft tissue sarcomas.

Authors:  B Ashleigh Guadagnolo; Ying Xu; Gunar K Zagars; Janice N Cormier; Raphael E Pollock; Barry W Feig; Sharon Giordano; Thomas A Buchholz; Ya-Chen Tina Shih
Journal:  Am J Clin Oncol       Date:  2012-10       Impact factor: 2.339

6.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

7.  Residual disease following unplanned excision of soft-tissue sarcoma of an extremity.

Authors:  S Noria; A Davis; R Kandel; J Levesque; B O'Sullivan; J Wunder; R Bell
Journal:  J Bone Joint Surg Am       Date:  1996-05       Impact factor: 5.284

8.  Cost of care for elderly cancer patients in the United States.

Authors:  K Robin Yabroff; Elizabeth B Lamont; Angela Mariotto; Joan L Warren; Marie Topor; Angela Meekins; Martin L Brown
Journal:  J Natl Cancer Inst       Date:  2008-04-29       Impact factor: 13.506

Review 9.  Surgical considerations when reporting MRI studies of soft tissue sarcoma of the limbs.

Authors:  Marcela De La Hoz Polo; Elizabeth Dick; Rej Bhumbra; Rob Pollock; Ranbir Sandhu; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2017-09-07       Impact factor: 2.199

10.  Studying radiation therapy using SEER-Medicare-linked data.

Authors:  Beth A Virnig; Joan L Warren; Gregory S Cooper; Carrie N Klabunde; Nicola Schussler; Jean Freeman
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

View more
  1 in total

1.  The Impact of Unplanned Excision on the Outcomes of Patients With Soft Tissue Sarcoma of the Trunk and Extremity: A Propensity Score Matching Analysis.

Authors:  Yao Liang; Tian-Hui Guo; Bu-Shu Xu; Dong-Chun Hong; Hai-Bo Qiu; Zhi-Wei Zhou; Xing Zhang
Journal:  Front Oncol       Date:  2021-01-22       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.